Clinical Trial Update: Evaluation, the Histomorphometric Study of Nanocrystalline Hydroxyapatite (Nano Bone) Wif Lovastatin in the Preservation of the Tooth Socket [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating nanocrystalline hydroxyapatite (Nano Bone) with lovastatin for preservation of the tooth socket in bone loss.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Loss

Drugs mentioned

• Lovastatin (Lovastatin)
• Nano Bone (nanocrystalline hydroxyapatite)

Snippet

Sponsor: Islamic Azad University, Sanandaj | Conditions: Bone Loss | Phase 2 | Status: UNKNOWN